FDA daily for Saturday, September 19, 2026
In this issue: 42 shortage updates and 29 label changes. 4 items touch categories MedGrid carries, and they come first.
For MedGrid's categories
Items in this issue that name a product category sold on MedGrid. Each links to its full FDA record; the chip opens that category's federal and state rules.
- Liraglutide Injection
Hikma Pharmaceuticals USA, Inc. · Available
- Sterile Water Injection
Hikma Pharmaceuticals USA, Inc. · Available
Drug shortages
FDA date:FDA updated 42 shortage entries on Fri, Sep 18: 2 new, 2 to be discontinued, 38 status updates.
- Liraglutide Injection
Hikma Pharmaceuticals USA, Inc. · Available
- Sterile Water Injection
Hikma Pharmaceuticals USA, Inc. · Available
- Rivastigmine Film, Extended Release
Mylan Pharmaceuticals Inc., a Viatris Company
- Rivaroxaban For Suspension
Janssen Pharmaceuticals
- Rocuronium Bromide Injection
Hikma Pharmaceuticals USA, Inc. · Available
- Promethazine Hydrochloride Injection
Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug
- Lisdexamfetamine Dimesylate Capsule
Hikma Pharmaceuticals USA, Inc. · Limited Availability · Reason: Shortage of an active ingredient
- Lorazepam Injection
Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other
- Fentanyl Citrate Injection
Hikma Pharmaceuticals USA, Inc. · Available
- Cefotaxime Sodium Powder, for Solution
Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Demand increase for the drug
- Ketorolac Tromethamine Injection
Hikma Pharmaceuticals USA, Inc. · Unavailable · Reason: Other
- Lidocaine Hydrochloride Injection
Hikma Pharmaceuticals USA, Inc. · Available
- Technetium TC-99M Pyrophosphate Kit Injection
Sun Pharmaceutical Industries, Inc. · Unavailable · Reason: Other
- Furosemide Oral Solution
Hikma Pharmaceuticals USA, Inc. · Available · Reason: Shortage of an inactive ingredient component
Label updates
FDA date:29 drug labels took effect on Sat, Sep 5; 10 of the 25 read for this issue are for products in MedGrid's categories. Below: those, and labels carrying a boxed warning.
- Juyasuyon Invisible Sunscreen
HOMOSALATE,OCTOCRYLENE,OCTISALATE,BEMOTRIZINOL,AVOBENZONE · Guangdong Aimu Biological Technology Co., Ltd · TOPICAL
FDA did not answer for Clearances, Drug recalls, Approvals, Device recalls, Food and supplement recalls while this issue was written; those sections will fill in on a later visit.
How the FDA daily is written
Every issue is written from FDA's public data (openFDA) and nothing else: the counts, names, firms and reasons are FDA's own. openFDA posts each kind of record on its own delay, so each section covers one FDA date and says which. Shortages cover yesterday; approvals, drug and device recalls, and food and supplement recalls cover a week ago; device clearances and label changes cover two weeks ago. Every FDA date appears in exactly one issue. Complete response letters appear the day after FDA publishes a batch.
Subscribe with any feed reader, or point an email tool at the RSS feed to send each issue as a newsletter. Search any drug, device or company across every FDA dataset in the FDA data explorer.
